TallyHQ
github
Client · LDA

BIOGEN

5 filings 12 bills mentioned 1 registrants 5 quarters ~$5,620,000 reported
Client ID
155476

Bills lobbied on

Bills referenced in this client's quarterly filings, ranked by filing count.

S 832
EPIC Act of 2025
HCRPHA
4
HR 1492
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
HCRPHA
4
HR 946
ORPHAN Cures Act
PHA
2
S 864
HELP Copays Act
HCR
2
HR 1262
Mikaela Naylon Give Kids a Chance Act
HCR
1
HR 4317
PBM Reform Act of 2025
PHA
1
S 3267
ASAP Act
HCR
1
S 3345
PBM Price Transparency and Accountability Act
PHA
1
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
TAX
1
HR 6837
To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.
PHA
1
HR 6130
ASAP Act
HCR
1
HR 3747
AADAPT Act
HCR
1

Registrants

Lobbying firms that filed on behalf of this client.

BIOGEN 5

Source: Senate LDA quarterly filings (LD-2). Bill mentions extracted from free-text "specific issues" descriptions.